Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesSleep MedicineAetna SNAP Acoustic Pharyngometry Coverage Update …
    Ask Trek AI about this page
    CurrentAetnaPolicy 0336

    Acoustic Pharyngometers and SNAP Testing System

    Customize your policy alerts

    Sign up for Aetna Policy 0336 alerts

    Get alerted when Policy 0336 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs Aetna's coverage stance for acoustic pharyngometry devices and variants of the SNAP Testing System for evaluation of obstructive sleep apnea (OSA), specifying which device configurations are considered medically necessary versus experimental/investigational for adults.

    Policy Summary
    PayerAetna
    PolicyAcoustic Pharyngometers and SNAP Testing System
    Policy CodePolicy 0336
    Change TypeNo material change
    Effective DateJun 25, 1999
    Last ReviewMay 2, 2023
    Next Review DateMar 28, 2024
    Key ActionDocument device model and FDA 510(k) number when relying on device-level clearance for coverage decisions; use HCPCS G0400 for home sleep testing with a minimum of 3 channels when selection criteria are met.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    SNAP ≥3medically necessary

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    SNAP <3
    experimental/investigational
    Acoustic pharyngometryexperimental/investigational
    ~0.60discriminative ability (AUC)
    510(k) clearedFDA-cleared devices referenced
    03/28/2024Next review

    Coverage Criteria

    Not Medically Necessary / Experimental

    Covered when ALL of the following are met:

    ref":"b0_0","title":"Initial Diagnostics (Home sleep testing with ≥3 channels)"},{
    citations':['3','6','7']
    nodes([

    Aetna permits use of the SNAP Testing System only when the device records a minimum of 3 channels and the criteria in CPB 0004 - Obstructive Sleep Apnea in Adults are met; in that specific context SNAP (≥3 channels) is considered medically necessary for home diagnosis of OSA in adults. Documentation should support use of a type IV home sleep test (HCPCS G0400) with at least 3 channels when submitting for coverage.

    Conversely, acoustic pharyngometry (for example, the Eccovision Acoustic Pharyngometer) and versions of the SNAP Testing System that record fewer than 3 channels are considered experimental and investigational for screening, diagnosis, treatment planning, prediction of surgical success in suspected or known OSA, and for all other indications because effectiveness has not been established and these configurations may be insufficient to support clinical decisions.

    Acoustic pharyngometry measurements should not be treated as interchangeable with cone beam computed tomography (CBCT). A study comparing AP with CBCT found only a moderate correlation for area (r = 0.43) and volume (r = 0.59) and the authors concluded the two methods are not interchangeable; therefore AP should not be used to replace CBCT when CBCT is required for clinical decision-making.

    Practitioners should recognize measurement limitations of AP and SNAP devices: many published studies are feasibility or nonrandomized designs, often performed by experienced operators under awake/upright conditions that may not reflect sleep physiology. These limitations reduce the ability of AP-derived measures to serve as sole diagnostic evidence for OSA.

    Versions of the SNAP Testing System that use fewer than 3 channels and acoustic pharyngometry devices are explicitly designated not medically necessary / experimental and investigational for all OSA-related uses. The policy states there is insufficient evidence that home SNAP devices with <3 channels are as effective as conventional sleep studies for diagnosis and treatment planning, and thus these configurations may be denied.

    FDA 510(k) clearance of a device does not by itself establish clinical effectiveness or interchangeability with gold-standard diagnostic tests; the policy therefore distinguishes device regulatory status from medical necessity and treats SNAP <3-channel versions and acoustic pharyngometry as investigational despite any 510(k) clearance.

    Major diagnostic reviews do not support acoustic pharyngometry as a standalone diagnostic tool for obstructive sleep apnea. For example, an UpToDate review on clinical presentation and diagnosis of OSA does not mention acoustic pharyngometry, and the literature documents reproducibility and validity concerns for AP measures.

    Because AP studies frequently involve awake, seated measurements, experienced operators, and nonrandomized or feasibility designs, Aetna does not support use of acoustic pharyngometry as the sole basis for diagnosing OSA or for making definitive treatment decisions; reliance on AP alone carries a risk of claim denial.

    Coding

    HCPCS Covered if selection criteria metHCPCSCovered
    G0400Home sleep test (HST) with type IV portable monitor, unattended; minimum of 3 channels [covered for adults only]
    ICD-10 codes covered if selection criteria are met (examples and ranges listed)ICD-10
    F51.03 - F51.05Insomnia and hypersomnia not due to a substance or known physiological condition
    F51.13 - F51.19Insomnia and hypersomnia not due to a substance or known physiological condition
    F51.8Other sleep disorders not due to a substance or known physiological condition
    G47.00 - G47.39Sleep disorders
    G47.50 - G47.9Sleep disorders
    R06.00 - R06.09Abnormalities of breathing
    R06.83 - R06.89Abnormalities of breathing
    R06.81Apnea, not elsewhere classified
    Acoustic pharyngometrymixedNot Covered
    None specifiedNo specific CPT/HCPCS code listed for acoustic pharyngometry device
    Referenced FDA 510(k) numbersmixed
    K011329Eccovision Acoustic Diagnostic Imaging Acoustic Pharyngometer (FDA 510(k) No. K011329)
    K992322Snap Model 5. Apnea/snoring recording and analysis device and oximeter (FDA 510(k) No. K992322)
    HST channel requirement — minimum of 3 channels
    RequirementHome sleep test (HST) with a type IV portable monitor must record a minimum of 3 channels to meet covered criteria (HCPCS G0400).
    ScopeApplies to SNAP Testing System configurations used for home diagnosis of OSA in adults when selection criteria are met.
    Consequence of noncomplianceVersions of SNAP with fewer than 3 channels are considered experimental/investigational and are not covered.

    Provider Actions and Documentation

    Prior Authorization

    Prior authorization required for HST (≥3 channels)

    Home sleep test (HST) using a type IV portable monitor with a minimum of 3 channels (HCPCS G0400) is covered for adults when selection criteria in CPB 0004 are met; submit prior authorization referencing G0400 and the applicable CPB 0004 criteria.

    • Use HCPCS code G0400 for prior auth submission.
    • Ensure patient meets CPB 0004 selection criteria for OSA diagnosis.
    Documentation Required

    Document device model and FDA 510(k) when requested

    If device-level clearance is required by the payer, document the exact device model and the FDA 510(k) number (for example, Eccovision K011329 or SNAP Model 5 K992322) in the authorization and medical record.

    • Provide manufacturer and model name.

    Definitions

    Acoustic pharyngometer (Eccovision™) — device description
    Device nameEccovision™ Acoustic Reflection Pharyngometer (acoustic pharyngometer)
    Operating principleUses incident and reflected sound waves to produce an area–distance curve of the upper airway from which minimal cross-sectional area and volume are derived.
    Clinical useMarketed as a noninvasive screening method to assess potential sites of sleep-related upper airway obstruction and to inform oral appliance vs CPAP selection.
    SNAP Testing System — device description and channel variability
    Device familySNAP Testing System (SNAP Laboratories) — reflective acoustic device marketed to locate snoring source and detect sleep apnea.
    Channel variabilityVersions vary: earlier/home versions can record fewer than 3 channels (type IV) while newer versions record multiple physiologic channels including airflow, SaO2, pulse rate, respiratory effort, respiratory sounds and body position.

    Background

    Acoustic pharyngometry noninvasively derives an area–distance curve of the upper airway by emitting and recording reflected sound waves to estimate cross‑sectional area and pharyngeal volume. It has been investigated for screening for OSA, assisting oral appliance positioning, and documenting anatomic changes after surgery, but studies vary in design and quality. Correlations with OSA severity and with imaging (eg, CBCT) have been reported, yet reproducibility and clinical interchangeability with gold‑standard methods remain limited.

    Policy Summary
    PayerAetna
    PolicyAcoustic Pharyngometers and SNAP Testing System
    Policy CodePolicy 0336
    Change TypeNo material change
    Effective DateJun 25, 1999
    Last ReviewMay 2, 2023
    Next Review DateMar 28, 2024
    Key ActionDocument device model and FDA 510(k) number when relying on device-level clearance for coverage decisions; use HCPCS G0400 for home sleep testing with a minimum of 3 channels when selection criteria are met.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider Actions and DocumentationDefinitionsBackground
  1. Include FDA 510(k) number in supporting documentation when requested.
  2. Step Therapy

    Use established diagnostic steps first

    Follow established diagnostic pathways (eg, polysomnography or type III/IV devices per CPB 0004) before relying on acoustic pharyngometry or single-/fewer‑channel SNAP systems to guide clinical decisions.

    • Consider polysomnography or validated home sleep testing prior to using AP/SNAP for treatment planning.
    • Do not substitute AP/SNAP (<3 channels) for standard diagnostic tests.
    Note

    Consider established diagnostic steps first (clinical caution)

    Recognize that studies of acoustic pharyngometry often used experienced operators and non-randomized designs; consider validated diagnostic methods (eg, polysomnography, type III devices) prior to using AP to direct therapy.

    • AP measures may lack reproducibility and validity outside experienced operators.
    • Prefer standard diagnostic tests for treatment decisions.
    Documentation Required

    Document device type, channel count, and selection criteria for HST

    When submitting claims for HCPCS G0400, include documentation that the test used a type IV portable monitor with at least 3 channels and that patient selection criteria in CPB 0004 were met; retain the HST report in the medical record.

    • Document device type (type IV) and channel count (≥3) in the chart and claim support.
    • Keep the HST report and interpretation available for review.
    Documentation Required

    Document diagnostic device and scoring in protocols/studies

    If acoustic pharyngometry or SNAP is used within a study or clinical protocol, record the device type, scoring method, and baseline/follow‑up sleep study methodology (including whether manual scoring was used) to support interpretation of results.

    • Specify device and scoring method in study records.
    • Document baseline and follow‑up sleep study devices and whether manual scoring was performed.
    Denial Risk

    Denial risk: AP and SNAP versions with <3 channels

    Use of acoustic pharyngometry or SNAP systems with fewer than 3 channels for screening, diagnosis, treatment planning, or prediction of surgical success is considered experimental/investigational and may be denied.

    • Do not rely on AP or SNAP <3 channels for clinical decisions expecting coverage.
    • Expect denials for claims using these devices for OSA‑related indications.
    Denial Risk

    Denial risk if AP used as sole diagnostic evidence

    Acoustic pharyngometry has reproducibility and validity limitations and is not referenced in major diagnostic reviews (eg, UpToDate); using AP as the sole diagnostic evidence for OSA may be insufficient to support coverage and could be denied.

    • Avoid using AP alone to establish OSA diagnosis for coverage purposes.
    • Provide corroborating sleep study data when AP findings are used.
    Regulatory statusSome SNAP devices received FDA 510(k) clearance; cleared status does not establish equivalence to polysomnography.
    Minimum cross-sectional area (MCSA) — definition
    DefinitionMinimum cross-sectional area (MCSA): the smallest airway cross-sectional area within the pharynx measured by acoustic pharyngometry used to assess airway patency.
    Measurement originDerived from the area–distance curve generated by reflected sound waves from acoustic pharyngometry.
    Clinical contextUsed in studies to quantify anatomical changes before and after interventions (eg, expansion sphincter pharyngoplasty) but not shown to predict surgical success reliably.
    Total pharyngeal volume (TPV) — definition
    DefinitionTotal pharyngeal volume (TPV): the measured volume of the pharyngeal lumen obtained by acoustic pharyngometry to evaluate anatomic changes.
    Measurement contextCalculated from the area–distance curve produced by acoustic reflection methods (Eccovision™) covering oral cavity to hypopharynx.
    Clinical useApplied in pre- and post-operative comparisons to document upper airway anatomical changes, though TPV changes have not reliably predicted surgical outcomes alone.